Max Bayer – Page 13 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

US inks $113M deal with Siga to bolster smallpox, mpox reserves

11 months ago

Roivant recently sold one spinout for billions. Is Priovant next?

11 months ago

Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post

11 months ago

Novartis CEO: Trying to crack obesity market with another first-gen agent is 'not a prudent approach'

11 months ago

Cassava founder and CEO resigns as federal probes progress

11 months ago

Federal judge dismisses Hawaii’s lawsuit against top three PBMs

11 months ago

Roche details early obesity data from GLP-1/GIP agonist, plans for Phase 2 study this year

11 months ago

Facing a tepid Alzheimer’s market, Lilly looks to build ‘a sense of urgency’ to jumpstart sales of donanemab

11 months ago

Lilly says lupus drug dropped from pipeline failed to show efficacy

11 months ago

Indivior axes schizophrenia drug and shrinks revenue guidance

11 months ago

AbbVie asks Supreme Court to reconsider ruling on attorney-client communication

11 months ago

AbbVie CSO Tom Hudson to retire, replaced by medical chief

11 months ago

Arcutis tacks on atopic dermatitis approval for Zoryve cream

11 months ago

Six big R&D questions for Pfizer as science chief Dolsten exits

11 months ago

Acquired biotech accuses Novartis of letting IL-15 asset 'wither on the vine'

11 months ago

Lilly bests Novo Nordisk in observational study of GLP-1 drugs

11 months ago

Experts want to make it easier to get RSV vaccines. Did they make it harder instead?

11 months ago

Moderna wins $176M BARDA award to finance bird flu work

11 months ago

Cassava says two senior employees included in federal probes

11 months ago

Aerovate plans to lay off nearly all employees after trial failure

11 months ago

EMA's CHMP recommends 10 new drugs as Pierre Fabre overactive bladder med wins approval

12 months ago

Inside BARDA's multibillion-dollar effort to fund long-shot biotechs for Covid

12 months ago

Lykos takes another hit as ICER lays out 'insufficient' evidence for MDMA-based treatment

12 months ago

Updated: CDC expands RSV vaccine recommendations, namely for adults 75 and older

12 months ago

First page Previous page 10 11 121314 Next page Last page